ID: ALA431556

Max Phase: Preclinical

Molecular Formula: C24H19ClF7NO3

Molecular Weight: 537.86

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  OC(CN(Cc1cccc(OC(F)(F)C(F)F)c1)c1cccc(Oc2ccccc2Cl)c1)C(F)(F)F

Standard InChI:  InChI=1S/C24H19ClF7NO3/c25-19-9-1-2-10-20(19)35-17-7-4-6-16(12-17)33(14-21(34)23(28,29)30)13-15-5-3-8-18(11-15)36-24(31,32)22(26)27/h1-12,21-22,34H,13-14H2

Standard InChI Key:  KEYWFGQIWUCOPC-UHFFFAOYSA-N

Associated Targets(Human)

Cholesteryl ester transfer protein 2422 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cholesteryl ester transfer protein 233 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 537.86Molecular Weight (Monoisotopic): 537.0942AlogP: 7.30#Rotatable Bonds: 10
Polar Surface Area: 41.93Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 2HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.04CX Basic pKa: CX LogP: 7.39CX LogD: 7.39
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.28Np Likeness Score: -1.02

References

1. Reinhard EJ, Wang JL, Durley RC, Fobian YM, Grapperhaus ML, Hickory BS, Massa MA, Norton MB, Promo MA, Tollefson MB, Vernier WF, Connolly DT, Witherbee BJ, Melton MA, Regina KJ, Smith ME, Sikorski JA..  (2003)  Discovery of a simple picomolar inhibitor of cholesteryl ester transfer protein.,  46  (11): [PMID:12747787] [10.1021/jm020528+]
2. Castilho MS, Guido RV, Andricopulo AD..  (2007)  2D Quantitative structure-activity relationship studies on a series of cholesteryl ester transfer protein inhibitors.,  15  (18): [PMID:17604633] [10.1016/j.bmc.2007.06.021]
3. Abu Khalaf R, Abu Sheikha G, Bustanji Y, Taha MO..  (2010)  Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration.,  45  (4): [PMID:20116902] [10.1016/j.ejmech.2009.12.070]
4. Kelkar MA, Pednekar DV, Pimple SR, Akamanchi KG.  (2004)  3D QSAR STUDIES OF INHIBITORS OF CHOLESTEROL ESTER TRANSFER PROTEIN (CETP) BY CoMFA, CoMSIA AND GFA METHODOLOGIES,  13  (8): [10.1007/s00044-004-0104-9]

Source